Marc Fenster

Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis

Parakkal Deepak, Quazim A. Alayo, Aava Khatiwada et al. · Clinical Gastroenterology and Hepatology · 2020 · 103 citations · Full text

Clinical Epidemiology, Gastroenterology, Therapeutic Controversy +5

Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease

Quazim A. Alayo, Marc Fenster, Osama Altayar et al. · Crohn s & Colitis 360 · 2022 · 74 citations · Full text

Real-World Effectiveness and Safety of Tofacitinib in Crohn’s Disease and IBD-U: A Multicenter Study From the TROPIC Consortium

Marc Fenster, Quazim A. Alayo, Aava Khatiwada et al. · Clinical Gastroenterology and Hepatology · 2020 · 36 citations · Full text

Chronic Inflammatory Diseases, Anti-inflammatory, Real-world Effectiveness +8

P344 Real-world effectiveness of tofacitinib in ulcerative colitis: a multi-centre study

Ryan C. Ungaro, Marc Fenster, Christina Dimopoulos et al. · Journal of Crohn s and Colitis · 2019 · 16 citations · Full text

Bio-naïve Status, Gastrointestinal Pharmacology, P344 Real-world Effectiveness +16

Real‐world multicentre experience of the pathological features of colonic ischaemia and their relationship to symptom duration, disease distribution and clinical outcome

Marc Fenster, Paul Feuerstadt, Lawrence J. Brandt et al. · Colorectal Disease · 2018 · 15 citations